Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Liquidia Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
LQDA
Nasdaq
2830
www.liquidia.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Liquidia Corporation
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
- Aug 6th, 2026 9:41 am
EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus
- Aug 6th, 2026 9:26 am
Immunovant's Q1 Loss Wider Than Expected, Pipeline in Progress
- Aug 6th, 2026 9:22 am
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised
- Aug 6th, 2026 9:21 am
ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness
- Aug 6th, 2026 8:50 am
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
- Aug 6th, 2026 7:03 am
Zacks Investment Ideas feature highlights: Lenovo, Victoria's Secret and Liquidia
- Aug 6th, 2026 4:28 am
Should YUTREPIA’s Profit-Driven Momentum Prompt a Fresh Look at Liquidia’s (LQDA) Investment Case?
- Aug 5th, 2026 11:09 pm
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up
- Aug 5th, 2026 12:50 pm
3 Top Ranked Stocks Breaking Out Now
- Aug 5th, 2026 12:40 pm
Pacira Q2 Earnings & Revenues Beat, 2026 Sales Outlook Cut
- Aug 5th, 2026 10:16 am
Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y
- Aug 5th, 2026 9:49 am
ACAD Q2 Earnings and Revenues Beat, '26 View Raised on Product Sales
- Aug 5th, 2026 9:44 am
BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus
- Aug 5th, 2026 9:10 am
SYRE's Q2 Loss Narrower Than Expected, Pipeline Progresses
- Aug 5th, 2026 9:08 am
IBRX Q2 Earnings & Sales Beat Estimates on Strong Anktiva Uptake
- Aug 5th, 2026 8:53 am
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
- Aug 4th, 2026 10:18 am
CRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates
- Aug 4th, 2026 8:56 am
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus
- Aug 4th, 2026 8:56 am
KROS Q2 Earnings Miss as Revenues Fall to Zero, Pipeline in Focus
- Aug 4th, 2026 8:43 am
Scroll